Pfizer To Acquire Medivation

Go back to Pfizer To Acquire Medivation

Barclays Downgrades Medivation (MDVN) to Equalweight

August 23, 2016 6:58 AM UTC

Barclays downgraded Medivation (NASDAQ: MDVN) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $80.42 yesterday.

... More

Citi Downgrades Medivation (MDVN) to Neutral

August 22, 2016 2:43 PM UTC

Citi downgraded Medivation (NASDAQ: MDVN) from Buy to Neutral.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More

Brean Capital Downgrades Medivation (MDVN) to Hold

August 22, 2016 1:01 PM UTC

Brean Capital downgraded Medivation (NASDAQ: MDVN) from Buy to Hold.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More

Wedbush Downgrades Medivation (MDVN) to Neutral

August 22, 2016 1:00 PM UTC

Wedbush downgraded Medivation (NASDAQ: MDVN) from Outperform to Neutral.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More